Related references
Note: Only part of the references are listed.A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
Martin J. Boeree et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool
Klaus Romero et al.
CLINICAL INFECTIOUS DISEASES (2015)
Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study
Matthew Bates et al.
LANCET INFECTIOUS DISEASES (2015)
Towards host-directed therapies for tuberculosis
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Tuberculosis and diabetes mellitus - an underappreciated association
Marcin Skowronski et al.
ARCHIVES OF MEDICAL SCIENCE (2014)
Ending the Global HIV/AIDS Pandemic: The Critical Role of an HIV Vaccine
Anthony S. Fauci et al.
CLINICAL INFECTIOUS DISEASES (2014)
Linezolid in the treatment of extensively drug-resistant tuberculosis
L. Zhang et al.
INFECTION (2014)
Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β′ subunit of RNA polymerase
Taeksun Song et al.
MOLECULAR MICROBIOLOGY (2014)
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Katrin D. Mayer-Barber et al.
NATURE (2014)
Evolution and transmission of drug-resistant tuberculosis in a Russian population
Nicola Casali et al.
NATURE GENETICS (2014)
Ending AIDS - Is an HIV Vaccine Necessary?
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting the Inflammatory Response in Tuberculosis
Jon S. Friedland
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Host Battles Drug-Resistant Tuberculosis
Markus Maeurer et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens
Philana Ling Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Deaths due to respiratory tract infections in Africa: a review of autopsy studies
Matthew Bates et al.
CURRENT OPINION IN PULMONARY MEDICINE (2013)
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
Ben J. Marais et al.
LANCET INFECTIOUS DISEASES (2013)
Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa
Colleen F. Hanrahan et al.
PLOS ONE (2013)
Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients
Matthias Merker et al.
PLOS ONE (2013)
The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis
Borna Mueller et al.
TRENDS IN GENETICS (2013)
Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes
Inaki Comas et al.
NATURE GENETICS (2012)
Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
Christina Yoon et al.
PLOS ONE (2012)
Averting epidemics of extensively drug-resistant tuberculosis
Sanjay Basu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates
SH Gillespie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)